In the original version of this article (1), There is a typographical error in the “Total” column of the “Objective response, n (%)g” row in Table 3. The error has been corrected in the latest online HTML and PDF versions of the article. The editors regret this error.
Reference
- 1. Munster P, Iannotti N, Cho DC, Kirkwood JM, Villaruz LZ, Gibney GT, et al. Combination of itacitinib or parsaclisib with pembrolizumab in patients with advanced solid tumors: a phase i study. Cancer Res Commun 2023;3:2572–84. [DOI] [PMC free article] [PubMed] [Google Scholar]